Prophylaxis for stress ulcer bleeding in the intensive care unit

Prophylaxis for stress ulcer bleeding in the intensive care unit

Background: The critically ill patient can develop gastric erosions and, on occasion, stress ulcers with severe gastrointestinal bleeding that can be fatal. Aims: The purpose of this review was to provide current information on the pathophysiology, risk factors, and prophylaxis of digestive tract bl...

Full description

Bibliographic Details
Main Authors:	J.M. Avendaño-Reyes, H. Jaramillo-Ramírez
Format:	Article
Language:	English
Published:	Elsevier 2014-01-01
Series:	Revista de Gastroenterología de México (English Edition)
Subjects:	Stress ulcer bleeding Intensive care unit Proton pump inhibitor H2 receptor antagonists Mexico
Online Access:	http://www.sciencedirect.com/science/article/pii/S2255534X14000334

Similar Items

Pharmacological Treatment for Peptic Ulcer Bleeding
by: Dae Won Ma, et al.
Published: (2018-12-01)

Stress ulcer prophylaxis with proton pump inhibitors or histamine 2 receptor antagonists in critically ill adults - a meta-analysis of randomized controlled trials with trial sequential analysis
by: Xiaoyang Zhou, et al.
Published: (2019-11-01)

Intravenous form of omeprazole will be replaced by oral form in patients with ulcer bleeding
by: A.V. Savustyanenko
Published: (2014-11-01)

Oral versus intravenous proton pump inhibitors in preventing re-bleeding for patients with peptic ulcer bleeding after successful endoscopic therapy
by: Yen Hsu-Heng, et al.
Published: (2012-06-01)

The principles of drug gastroduodenal bleeding prevention in critically ill condition patients and in postoperative period patients
by: Ye. A. Sorokina, et al.
Published: (2010-12-01)

Diagnosis and Treatment of Peptic Ulcer in Adults (Clinical Guidelines of the Russian Gastroenterological Association, Russian Society of Colorectal Surgeons and the Russian Endoscopic Society)
by: V. T. Ivashkin, et al.
Published: (2020-04-01)

Stress ulcer prophylaxis versus placebo or no prophylaxis in adult hospitalised acutely ill patients—protocol for a systematic review with meta-analysis and trial sequential analysis
by: Søren Marker, et al.
Published: (2017-06-01)

Comparison of Oral versus Intravenous Proton Pump Inhibitors in Preventing Re-bleeding from Peptic Ulcer after Successful Endoscopic Therapy
by: Seyed Mohammad Valizadeh Toosi, et al.
Published: (2018-10-01)

Intravenous non-high-dose pantoprazole is equally effective as high-dose pantoprazole in preventing rebleeding among low risk patients with a bleeding peptic ulcer after initial endoscopic hemostasis
by: Liang Chih-Ming, et al.
Published: (2012-03-01)

Hematologic and laboratory parameters in patientis with peptic ulcer bleeding treated by two modalities of endoscopic haemostasis and proton pompe inhibitors
by: Amila Mehmedović-Redžepović, et al.
Published: (2011-02-01)

Effects of high-dose versus low-dose proton pump inhibitors for treatment of gastrointestinal ulcer bleeding: a meta-analysis of randomized controlled trials
by: Chen, L., et al.
Published: (2022)

Effect of acid-reducing agents on clinical relapse in ulcerative colitis with pH-dependent-released 5-aminosalicylic acid: a multicenter retrospective study in Japan
by: Yosuke Shimodaira, et al.
Published: (2021-04-01)

Management of nonvariceal upper gastrointestinal bleeding
by: E Wee
Published: (2011-01-01)

Histamine2-Receptor Antagonists, Proton Pump Inhibitors, or Potassium-Competitive Acid Blockers Preventing Delayed Bleeding After Endoscopic Submucosal Dissection: A Meta-Analysis
by: Xin Jiang, et al.
Published: (2019-09-01)

Comparative characteristics of proton pump inhibitor effectiveness in the treatment of gastric ulcer and duodenal ulcer
by: Balitska Olesya P., et al.
Published: (2020-06-01)

Profilaxia das úlceras associadas ao estresse Prophylaxis of ulcers associated with stress
by: Carlos Eduardo Pompilio, et al.
Published: (2010-06-01)

Pharmacologic Management of Nonvariceal Upper Gastrointestinal Bleeding
by: Jeong Hwan Kim
Published: (2016-12-01)

Effect of Proton Pump Inhibitors on Risks of Upper and Lower Gastrointestinal Bleeding among Users of Low-Dose Aspirin: A Population-Based Observational Study
by: Luis A. García Rodríguez, et al.
Published: (2020-03-01)

Economic impact of pharmacist interventions on correction of stress-related mucosal damage prophylaxis practice
by: Mahmoudi L, et al.
Published: (2019-01-01)

Adjuvant drug therapy of bleeding from gastric or duodenal ulcer
by: Janković Slobodan
Published: (2015-01-01)

Liver cirrhosis is a risk factor of repeat acute hemorrhagic rectal ulcer in intensive care unit patients
by: Pi-Kai Chang, et al.
Published: (2014-01-01)

COMPARISON OF THE EFFICACIES OF PROTON PUMP INHIBITORS AND H2 RECEPTOR ANTAGONISTS IN ON-DEMAND TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE
by: Nesibe Vardı, et al.
Published: (2018-08-01)

Mucosal Healing Effectiveness and Safety of Anaprazole, a Novel PPI, vs. Rabeprazole in Patients With Duodenal Ulcers: A Randomized Double-Blinded Multicenter Phase II Clinical Trial
by: Xu Shu, et al.
Published: (2021-07-01)

The Management of Acute Upper Gastrointestinal Bleeding: A Comparison of Current Clinical Guidelines and Best Practice
by: Alison A. Taylor, et al.
Published: (2014-12-01)

Stress ulcer prophylaxis in patients being weaned from the ventilator in a respiratory care center: A randomized control trial
by: Chien-Chu Lin, et al.
Published: (2016-01-01)

Rabeprazole in the treatment of duodenal ulcer desease and functional dyspepsia
by: V. Yu. Rusyaev, et al.
Published: (2018-07-01)

Indication of acid suppression therapy and predictors for the prophylactic use of proton-pump inhibitors vs. histamine-2 receptor antagonists in a Malaysian tertiary hospital
by: Oh AL, et al.
Published: (2015-09-01)

Gastrointestinal bleeding in patients admitted to the intensive care unit
by: Ruxandra OPRITA, et al.
Published: (2018-12-01)

TREATMENT OF ULCER GASTRODUODENAL BLEEDINGS: CURRENT STATE OF THE PROBLEM (A LITERATURE REVIEW)
by: O. N. Antonov, et al.
Published: (2016-03-01)

The Skeletal Effects of Short-Term Triple Therapy in a Rat Model of Gastric Ulcer Induced by Helicobacter pylori Infection
by: Ekeuku SO, et al.
Published: (2020-12-01)

Efficacy of proton pump inhibitors for patients with duodenal ulcers: A pairwise and network meta-analysis of randomized controlled trials
by: Zhan-Hong Hu, et al.
Published: (2017-01-01)

Low-dose PPI to prevent bleeding after ESD: A multicenter randomized controlled study
by: Li Yang, et al.
Published: (2021-04-01)

Determination of the Risk of Recurrent Gastroduodenal Ulcer Bleeding
by: I. I. Dutka, et al.
Published: (2016-09-01)

Risk factors for rebleeding in patients with peptic ulcer bleeding
by: M V Valeev, et al.
Published: (2020-06-01)

Dysfunction of neutrophils in patients with peptic ulcers, complicated with bleeding
by: Sulayeva O.N.
Published: (2011-01-01)

State-of-the-art management of acute bleeding peptic ulcer disease
by: Hisham Al Dhahab, et al.
Published: (2013-01-01)

Interobserver variation in the endoscopic diagnosis of gastroduodenal ulcer scars: implications for clinical management of NSAIDs users
by: Ishimura Norihisa, et al.
Published: (2011-10-01)

Histamine-2 receptor antagonists versus proton pump inhibitors for septic shock after lower gastrointestinal tract perforation: a retrospective cohort study using a national inpatient database
by: Jun Suzuki, et al.
Published: (2020-07-01)

TACTICS OF TREATMENT OF PATIENTS WITH ULCERATIVE GASTRODUODENAL BLEEDING
by: Marmysh G. G., et al.
Published: (2018-05-01)

HISTORICAL PERSPECTIVE OF GASTROESOPHAGEAL REFLUX DISEASE CLINICAL TREATMENT
by: Schlioma ZATERKA, et al.